Atea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

Go back to Atea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
(NASDAQ: AVIR) Delayed: 5.26 +0.11 (2.14%)
Previous Close $5.15    52 Week High $2.00 
Open $5.21    52 Week Low $1.15 
Day High $5.33    P/E N/A 
Day Low $5.20    EPS $0.00 
Volume 279,429